Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Bedrijven · 28-1-20031 min lezen
Draft Guidance for Industry on Drug Product: Chemistry, Manufacturing, and Controls Information; Availability
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Drug Product: Chemistry, Manufacturing, and Controls Information." This draft guidance provides recommendations on the chemistry, manufacturing, and controls (CMC) information for drug products that should be submitted in original new drug applications (NDAs) and abbreviated new drug applications (ANDAs). The draft guidance is structured to facilitate the preparation of applications submitted in Common Technical Document (CTD) format.
Oorspronkelijke brontaal: Federal Register — Food and Drug AdministrationOrigineel bericht openen →